Annual Shareholders Equity
$8.54 M
-$90.77 M-91.40%
December 31, 2022
Summary
- As of February 10, 2025, EUCR annual stockholders equity is $8.54 million, with the most recent change of -$90.77 million (-91.40%) on December 31, 2022.
- During the last 3 years, EUCR annual shareholders equity has fallen by -$86.95 million (-91.06%).
Performance
EUCR Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
$8.54 M
-$93.05 M-91.60%
December 31, 2022
Summary
- As of February 10, 2025, EUCR quarterly stockholders equity is $8.54 million, with the most recent change of -$93.05 million (-91.60%) on December 31, 2022.
- Over the past year, EUCR quarterly shareholders equity has dropped by -$90.77 million (-91.40%).
Performance
EUCR Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
EUCR Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -91.4% | -91.4% |
| 3 y3 years | -91.1% | +10000.0% |
| 5 y5 years | -91.1% | +10000.0% |
EUCR Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -91.4% | at low | -91.6% | at low |
| 5 y | 5-year | -91.4% | at low | -91.6% | -99.7% |
| alltime | all time | -91.4% | at low | -91.6% | -99.7% |
Eucrates Biomedical Acquisition Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $8.54 M(-91.4%) | $8.54 M(-91.6%) |
| Sep 2022 | - | $101.58 M(+0.5%) |
| Jun 2022 | - | $101.06 M(+0.4%) |
| Mar 2022 | - | $100.63 M(+1.3%) |
| Dec 2021 | $99.31 M | $99.31 M(+0.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $99.06 M(+1.0%) |
| Jun 2021 | - | $98.11 M(+0.6%) |
| Mar 2021 | - | $97.48 M(>+9900.0%) |
| Dec 2020 | $95.48 M | - |
| Sep 2020 | - | $21.90 K(0.0%) |
| Aug 2020 | - | $21.90 K |
FAQ
- What is Eucrates Biomedical Acquisition annual stockholders equity?
- What is the all time high annual shareholders equity for Eucrates Biomedical Acquisition?
- What is Eucrates Biomedical Acquisition annual shareholders equity year-on-year change?
- What is Eucrates Biomedical Acquisition quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Eucrates Biomedical Acquisition?
- What is Eucrates Biomedical Acquisition quarterly shareholders equity year-on-year change?
What is Eucrates Biomedical Acquisition annual stockholders equity?
The current annual shareholders equity of EUCR is $8.54 M
What is the all time high annual shareholders equity for Eucrates Biomedical Acquisition?
Eucrates Biomedical Acquisition all-time high annual stockholders equity is $99.31 M
What is Eucrates Biomedical Acquisition annual shareholders equity year-on-year change?
Over the past year, EUCR annual stockholders equity has changed by -$90.77 M (-91.40%)
What is Eucrates Biomedical Acquisition quarterly stockholders equity?
The current quarterly shareholders equity of EUCR is $8.54 M
What is the all time high quarterly shareholders equity for Eucrates Biomedical Acquisition?
Eucrates Biomedical Acquisition all-time high quarterly stockholders equity is $101.58 M
What is Eucrates Biomedical Acquisition quarterly shareholders equity year-on-year change?
Over the past year, EUCR quarterly stockholders equity has changed by -$90.77 M (-91.40%)